It is not always easy to decide whether to utilize single use systems or stainless steel devices for the production of biopharmaceuticals. Single use systems offer a number of advantages over traditional stainless steel systems, so it is no surprise that they have become a widely accepted standard in the biopharma industry.
The following infographics highlight the differences between single use technology and stainless steel reactors in terms of safety, costs, use of energy and efficiency.
Single use systems have become increasingly popular over the past few years and they are now an established standard in the biopharmaceutical industry. As you can see, the advantages of single use systems far outnumber those of traditional steel reactors. So why are some manufacturers still hesitant when it comes to switching from stainless steel to single use?
Often the main deciding factor is scalability. While there are single use systems with capacities of up to 2000 l, handling such massive bags might prove difficult. As a consequence, many manufacturers of biopharmaceuticals fear damaging their bags.
Stainless steel tanks pose no such risk. On the other hand, the contamination rate is substantially higher. Additionally, cleaning and sterilization can be an issue; the same is true for wrongly positioned seals or liquid pathways.
However the case may be, new developments should never be ignored; after all, new technologies that allow for a more effective production process are key to staying competitive.
Single Use Support offers biopharmaceutical companies a new and reliable logistics process for liquids on the basis of standardized single use bags.